Russell F M, Carapetis J R, Mansoor O, Darcy A, Fakakovi T, Metai A, Potoi N T, Wilson N, Mulholland E K
Centre for International Child Health, Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Melbourne, Australia.
Clin Infect Dis. 2003 Dec 15;37(12):1593-9. doi: 10.1086/379717. Epub 2003 Nov 18.
The Haemophilus influenzae type b (Hib) disease burden among children <5 years old in 4 Pacific island countries (PICs) was estimated. The incidence of confirmed Hib meningitis was calculated using the numbers of culture-confirmed isolates. In addition, the World Health Organization (WHO) Hib Rapid Assessment Tool (RAT) was used to estimate the true Hib meningitis incidence and the number of Hib meningitis and pneumonia cases, as well as the number of deaths due to Hib meningitis and pneumonia. The Hib meningitis annual incidence in 3 PICs was 70-84 cases per 100,000 children <5 years old. For PICs, the RAT is likely to overestimate the Hib pneumonia burden, as it assumes a 5 : 1 ratio of Hib pneumonia to Hib meningitis. The true ratio is likely to be 1 : 1. The high Hib disease burden and the relative cost-effectiveness of Hib vaccine make the introduction of Hib vaccine a good investment for PICs, costing US1000 dollars-US10,000 dollars for each death prevented--a number that ignores savings from reductions in the cost of treatment.
对4个太平洋岛国(PICs)5岁以下儿童的b型流感嗜血杆菌(Hib)疾病负担进行了估算。使用培养确诊的分离株数量计算确诊Hib脑膜炎的发病率。此外,还使用了世界卫生组织(WHO)的Hib快速评估工具(RAT)来估算Hib脑膜炎的实际发病率、Hib脑膜炎和肺炎病例数,以及Hib脑膜炎和肺炎导致的死亡数。3个太平洋岛国中,Hib脑膜炎的年发病率为每10万名5岁以下儿童70 - 84例。对于太平洋岛国而言,RAT可能高估了Hib肺炎负担,因为它假定Hib肺炎与Hib脑膜炎的比例为5 : 1。实际比例可能为1 : 1。Hib疾病负担高,且Hib疫苗具有相对成本效益,这使得引入Hib疫苗对太平洋岛国来说是一项不错的投资,预防每例死亡的成本为1000美元至10000美元——这个数字未考虑治疗成本降低带来的节省。